title: Pharmacologic therapy for behavioral symptoms of Alzheimer's disease.
abstract: Behavioral signs and symptoms in dementia are common, morbid, classifiable, and treatable. The current state-of-the-art approach is to evaluate carefully for social or environmental causes, intercurrent medical conditions, or other triggers of the behavior and attempt to deal with those directly. When these conservative steps fail, there may be a role for medication. A rational approach typically hinges on matching the most dominant behavioral target symptoms to the most relevant medication class, the key information of which is summarized.
authors.affiliation: Department of Psychiatry, University of Rochester Medical Center and Monroe Community Hospital, Rochester, New York, USA.
authors.forename: P N
authors.initials: PN
authors.lastname: Tariot
authors.forename: J M
authors.initials: JM
authors.lastname: Ryan
authors.forename: A P
authors.initials: AP
authors.lastname: Porsteinsson
authors.forename: R
authors.initials: R
authors.lastname: Loy
authors.forename: L S
authors.initials: LS
authors.lastname: Schneider
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000150:complications*; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D015577:Geriatric Assessment; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology*; D018579:Patient Selection; D011595:Psychomotor Agitation / Q000188:drug therapy / Q000209:etiology; D011619:Psychotropic Drugs / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D012307:Risk Factors; D012893:Sleep Wake Disorders / Q000188:drug therapy / Q000209:etiology
chemical_list: D011619:Psychotropic Drugs